Background/Aims: Cyclic adenosine monophosphate (cAMP)-dependent type 2 regulatory subunit beta (Prkar2b) is a regulatory isoform of cAMP-dependent protein kinase (PKA), which is the primary target for cAMP actions. In oocytes, PKA and the pentose phosphate pathway (PPP) have important roles during the germinal vesicle (GV) stage arrest of development. Although the roles of the PKA signal pathway have been studied in the development of oocyte, there has been no report on the function of PRKAR2B, a key regulator of PKA. Methods: Using reverse transcription polymerase chain reaction (RT-PCR), quantitative real-time PCR (qRT-PCR), immunohistochemistry, and immunofluorescence, we determined the relative expression of Prkar2b in various tissues, including ovarian follicles, during oocyte maturation. Prkar2b-interfering RNA (RNAi) microinjection was conducted to confirm the effect of Prkar2b knockdown, and immunofluorescence, qRT-PCR, and time-lapse video microscopy were used to analyze Prkar2b-deficient oocytes. Results: Prkar2b is strongly expressed in the ovarian tissues, particularly in the growing follicle. During oocyte maturation, the highest expression of Prkar2b was during metaphase I (MI), with a significant decrease at metaphase II (MII). RNAi-mediated Prkar2b suppression resulted in MI-stage arrest during oocyte development, and these oocytes exhibited abnormal spindle formation and chromosome aggregation. Expression of other members of the PKA family (except for Prkaca) were decreased, and the majority of the PPP factors were also reduced in Prkar2b-deficient oocytes. Conclusion: These results suggest that Prkar2b is closely involved in the maturation of oocytes by controlling spindle formation and PPP-mediated metabolism.
Introduction
Cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) is the chief mediator of cAMP in a variety of mammalian cells [1, 2] . PKA is a well-studied holoenzyme of the protein kinase family [3, 4] , which functions as a hetero-tetramer form consisting of two catalytic (C) and two regulatory (R) subunits [5] . Murine PKA is comprised of four R subunits (RIα, RIβ, RIIα, and RIIβ) and two C subunits (Cα and Cβ) [3, 4] . When cAMP is bound to two sites of each R subunit, the C subunits separate, inducing phosphorylation of the Ser/ Thr residues of the target protein [3, 6] . Included in the PKA family is cAMP-dependent type 2 regulatory subunit beta (Prkar2b), a form of RIIβ; these genes are primarily expressed in brain tissue, brown adipose tissue, and white adipose tissue [7, 8] . Prkar2b has the ability to regulate leukemia cell differentiation [9] , plays a role in motoneurons [10] and alternative signaling of cAMP pathways [11] , suppresses the effect of cAMP responsive element binding protein (CREB) activity in T cells [12] , regulates adipocyte differentiation [13] , and plays an oncogenic role in prostate cancer [14] . A recent study found that Prkar2b-deficient mice experience a decrease in white adipose tissue and an increase in resting metabolic activity, body temperature, and lipid hydrolysis [7] . However, only a small number of studies have investigated PRKAR2B signaling; the role of PRKAR2B in oocyte development has not yet been elucidated.
Various cellular processes are controlled by cAMP, including cell growth, differentiation, ion channel conductivity, synaptic release of neurotransmitters, and gene transcription [15] , and is used as a second messenger in cells and for activation of different cAMP receptor molecules, which consist of ion channels and several PKA holoenzymes [15] . During oocyte maturation, cAMP-PKA signaling plays an important role in the regulation of meiosis [16] . A high concentration of cAMP activates PKA and arrests the oocyte in the GV stage, whereas decreased cAMP results in inactivation of PKA and resumption of meiosis [17] . Although PRKAR2B is part of the PKA family of proteins and is highly expressed in ovarian follicles, its role in oocyte maturation has not yet been determined.
Oocyte developmental processes are highly complex and dynamically regulated by various factors such as luteinizing hormone, anti-Müllerian hormone, and follicle stimulating hormone during folliculogenesis [18] [19] [20] [21] . In ovarian follicles, the oocyte is present in the diplotene dictyate stage until development of the pre-ovulatory follicle [22] [23] [24] . At ovulation, the oocyte is in a state of germinal vesicle (GV) arrest. During oocyte maturation, the oocyte enters the GV breakdown (GVBD) stage and then serially undergoes further meiotic divisions (metaphase I [MI] and metaphase II [MII]) until secondary meiotic arrest at fertilization. As meiotic division of the oocyte progresses, the chromosomes and spindle migrate to the cortex, establishing asymmetric positioning and resulting in polarity of the oocyte, which is induced by signal pathway proteins including CDC42, RAC, ARP2/3 complex, and RASD1 [25] [26] [27] [28] . Although several studies regarding significant processes during oocyte maturation have been performed, the detailed mechanisms of these processes, including the role of Prkar2b, have not yet been investigated. In this study, we determined the role of Prkar2b in mouse oocyte maturation.
Materials and Methods

Animals
All animal studies were carried out on 3-or 6-week-old ICR female mice and the total number of mice used in the study was approximately 100. Mice were housed in the Animal Care Facility of CHA University, maintained in a controlled environment, and supplied with a normal diet and water. Animal care was in compliance with the Guide for the Care and Use of Laboratory Animals and was approved by the Institutional Animal Care and Use Committee (IACUC NO.150047) of CHA University.
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RT-PCR and qRT-PCR
Mouse tissues were isolated from 6-week-old mice and total RNA prepared using Trizol reagent (Invitrogen, USA) according to the manufacturer's manual. The complementary DNA (cDNA) was synthesized using the TOPscript™ cDNA Synthesis Kit (Enzynomics, Korea) according to the manufacturer's instruction. Reverse transcription polymerase chain reaction (RT-PCR) was carried out using Solg™ Taq DNA Polymerase (SolGent, Korea). PCR conditions and primer sequences are provided in Table 1 . Quantitative real-time PCR (qRT-PCR) was performed using iQ™ SYBR Green Supermix (Bio-Rad Laboratories, USA). Experiments were normalized with H1 histone family member O, oocyte specific (H1foo) and glyceraldehyde-3-phosphate dehydrogenase (Gapdh).
Histology and immunostaining
Six-week-old mouse ovaries were fixed with 4% formaldehyde for 2 days and embedded in paraffin. Sectioned samples (5 μm thickness) were applied to slides (Fisher Scientific, USA) and dried overnight. Following deparaffinization with xylene, immunohistochemistry was performed as previously described using rabbit anti-PRKAR2B antibody (1:100 dilution, Abcam, UK, cat# ab75993) [29] .
Immunofluorescence was performed on mouse oocytes. The oocytes were washed 3 times with 0.1% polyvinyl alcohol in phosphate-buffered saline (PVA-PBS) at room temperature. Oocytes were then fixed in fixation solution (4% paraformaldehyde in PVA-PBS) for 2 min and treated with permeabilization solution (0.5% Triton X-100 in PVA-PBS) for 20 min at room temperature. Oocytes were washed 3 times with PVA-PBS and incubated in 1% bovine serum albumin in PVA-PBS (1% BSA-PVA-PBS) at 4°C overnight. The oocytes were then transferred to blocking solution (3% BSA in PVA-PBS) for 1 h at room temperature. After blocking, oocytes were treated with anti-PRKAR2B (1:100 dilution, Abcam, cat# ab75993) and anti-α-tubulin (1:100 dilution, Santa Cruz Biotechnology, USA, cat# sc-8035) in 1% BSA-PVA-PBS at 4°C overnight. After washing 3 times in PVA-PBS, oocytes were incubated in secondary antibody conjugated to Alexa Fluor 546 immunoglobulin (IgG) (1:100 dilution, Invitrogen, cat# A11001 and A11010) in 1% BSA-PVA-PBS at 4°C for 1 h. After washing, oocyte nuclei and F-actin were stained with 4΄,6-diamidino-2-phenylindole (DAPI) (1:200 dilution, D3571, Invitrogen) and phalloidin (1:200 dilution, Invitrogen, cat# A12379), respectively, for 10 min at room temperature. Samples were then mounted with Malinol mounting medium (Muto, Japan).
Preparation of dsRNA
Partial sequences of the Prkar2b coding region were amplified using Prkar2b-specific primers (Table  1) , and then cloned into pGEM-T Easy Vector (Promega, USA) for sense and anti-sense strands. Prkar2b clones were linearized with SpeI and sense or anti-sense RNAs were in vitro transcribed by T7 polymerase using the MEGAscript Kit (Ambion, USA). Sense and anti-sense strands were mixed, hybridized at 75°C for 5 min, and then slowly cooled to room temperature. The remaining nucleic acids were removed with DNase I and RNase A. After ethanol precipitation, double-stranded RNA (dsRNA) was dissolved in Tris-EDTA (TE) buffer (3.3 µg/µl) and stored at -80°C.
Collection and microinjection of oocytes and in vitro culture
Three-week-old ICR female mice were intraperitoneally injected with 5 IU of pregnant mare serum gonadotropin (PMSG; Sigma-Aldrich, USA). After 43-45 h, mice were sacrificed and their ovaries isolated and maintained in M2 medium (Sigma-Aldrich) with 0.2 mM 3-isobutyl-1-methylxanthine (IBMX; SigmaAldrich). Ovaries were pierced with a 26-gauge needle and cumulus-enclosed oocyte complexes (COCs) collected. Cumulus cells (CCs) were then removed from COCs and GV oocytes obtained using a fine-bore pipette. CCs and granulosa cells (GCs) were collected and stored at -80°C. Prkar2b dsRNA (10 pl of 3.3 µg/ µl) was microinjected into the cytoplasm of the GV stage oocytes (in M2 medium with 0.2 mM IMBX). A constant-flow system (FemtoJet; Eppendorf, Germany) was used for microinjection. Green fluorescent protein (GFP) dsRNA was used as a control. Microinjected GV oocytes were cultured in 5% CO 2 at 37°C in M16 medium (Sigma-Aldrich) with 0.2 mM IMBX in order to degrade the target transcript. After 8 h, culture medium was replaced with M16 medium containing 3 mg/ml BSA (Sigma-Aldrich) and oocytes were incubated in 5% CO₂ at 37°C for 16 h, after which the maturation rate was determined.
Oocyte mRNA isolation and cDNA synthesis Oocyte messenger RNA (mRNA) preparation was accomplished using the Dynabeads mRNA DIRECT Kit (Dynal, Norway). Dynabeads oligo(dT) 25 beads (10 µl) were prewashed by combining them with lysis/ binding buffer (100 mM Tris-HCl [pH 7.5], 500 mM LiCl, 10 mM EDTA, 1% LiDS, and 5 mM dithiothreitol [DTT]) (300 µl). Oocytes were resuspended in the lysis/binding buffer, and then the prewashed Dynabeads oligo(dT) 25 were added to the oocyte lysate and incubated for 3 min at room temperature. The samples were then subjected to a Dynal magnetic particle concentrator (MPC)-S, the RNA-binding beads washed with buffer A (10 mM Tris-HCl [pH 7.5], 0.15 M LiCl, 1 M EDTA, 0.1% LiDS) followed by buffer B (10 mM Tris-HCl [pH 7.5], 0.15 M LiCl, 1 M EDTA) for 1 min each at room temperature, and the beads were then pelleted under a magnetic field for 1 min. The RNA was then eluted in 13 µl 10 mM Tris-HCl [pH 7.5] at 70°C for 3 min. Eluted mRNA and 1 µl oligo(dT) were combined and annealed at 70°C for 10 min using the TOPscript™ cDNA Synthesis Kit (Enzynomics). After annealing, TOPscript™ Reverse Transcriptase (200 U/ ul), 10× TOPscript™ RT Buffer, dNTP mixture (2 mM each nucleotide), and RNase inhibitor (40 U/ul) were added and cDNA was synthesized at 42°C for 60 min. The reaction was halted by incubating at 95°C for 5 min.
Time lapse video microscopy
Time lapse video microscopy (JuLITM, Digital Bio, Korea) was used to determine the phenotype of the oocytes. Images of the oocytes in a 37°C CO 2 incubator were captured every 5 min for 36 h.
Statistical analyses
The experimental data were presented as the mean standard error of the mean (SEM). Real-time PCR data were analyzed using a one-way analysis of variance (ANOVA) for statistical evaluation. P-values were considered statistically significant.
Results
Expression of Prkar2b mRNA in mouse tissues
Because the dramatically changed genes during primordial follicle activation to primary follicles means that which play critical roles in ovarian follicle development, the expression levels of the whole genes in dormant follicles and growing follicles are analyzed using microarray analysis. Then, we selected the Prkar2b, a novel and less studied regulator, among the 947 up-regulated genes in activated follicles. To compare the expression level of Prkar2b mRNA in mouse tissues, RT-PCR and qRT-PCR were performed using various tissues such as small intestine, stomach, kidney, spleen, heart, liver, lung, brain, ovary, uterus, and testis from 6-week old mice. The results showed that Prkar2b was highly expressed in the ovary (Fig. 1A and 1B) . Additionally, to examine the expression levels of other PKA families in these tissues, alternative isoforms of PKA such as Prkar2a, Prkar1a, Prkar1b, Prkaca, and Prkacb were measured using RT-PCR, and the results indicated that only Prkar2b was highly expressed in mice ovary (Fig. 1A) . To further study of Prkar2b, we tested the anti-Prkar2b antibody by western blotting using flag-conjugated Prkar2b cloning vector in Hek-293T cells. The results showed that both anti-flag and anti-Prkar2b detected the proteins (Fig. 1D) . To identify whether Prkar2b is expressed in stage of follicles of ovary, immunohistochemistry was performed. The results indicated that Prkar2b was specifically expressed in grown follicles as graffian and pre-ovulatory follicles in mouse ovary (Fig. 1C) . These results suggest that Prkar2b may play an important role in the maturation process of oocyte.
Expression of Prkar2b during oocyte maturation
To examine whether Prkar2b has a critical role during oocyte maturation, Prkar2b expression levels were analyzed in the stages of oocyte maturation as GV, GVBD, MI, and MII by in vitro maturation experiment. RT-PCR and qRT-PCR showed that Prkar2b was significantly increased in the MI stage, whereas recovered during MII stage ( Fig. 2A and 2B) . RT-PCR and qRT-PCR analysis of Prkar2b at GV, GVBD, MI, and MII stages of oocyte development. H1foo was used as an oocytespecific internal control to normalize expression levels. Data are expressed as mean±SEM. The Student t-test was applied to calculate p-value. *p<0.05, $p<0.05. (C) Immunofluorescence staining of each stage of oocyte development using anti-PRKAR2B antibody. DAPI and phalloidin were used to detect chromosomes and F-actin-mediated oocyte membrane, respectively. Images were analyzed using a confocal microscope. 
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To further confirm the expression of PRKAR2B protein in the stage of oocyte maturation, immunofluorescence was performed using anti-PRKAR2B antibody. As same above, the PRKAR2B expression was high in the MI stage of oocytes (Fig. 2C) . These results indicate that Prkar2b may be essential to work on MI stage of oocyte.
Effects of Prkar2b knockdown on oocyte maturation
To identify the effect of inhibition of Prkar2b on oocyte maturation, double strand RNAmediated Prkar2b (dsPrkar2b) knockdown system was constructed for microinjection of oocyte. Prkar2b coding sequences were selected and the primers confirming knockdown were designed (Fig. 3A) and the process of the dsRNA microinjection was performed with control (dsGFP) and dsPrkar2b (Fig. 3B) . After incubation for 16 hours, Prkar2b knockdown was confirmed during stage of oocyte maturation by RT-PCR and western blot analysis ( Fig. 3C and 3D) . Following dsRNA-injected oocytes maturation for 16 h, the morphology and polar body formation were analyzed. Most of control RNAi-injected oocytes were fully matured to MII stage, whereas about half of Prkar2b RNAi-injected oocytes were arrested at MI stage (Fig. 4A and 4B) . Time lapse video also showed that Prkar2b deficient oocytes were not developed and were no polar body formation compared with the control oocytes (Fig.  4C) . Taken together, these results mean that deficiency of Prkar2b suppresses development of MII stage of oocyte, and Prkar2b has a critical role during polar body formation on oocyte meiotic metaphase. 
Role of Prkar2b on spindle and polar body formation during oocytes maturation
To further confirm how Prkar2b affects polar body formation of oocyte meiosis, immunofluorescence was performed using anti-alpha tubulin antibody, a marker of spindle fiber, at MI and MII arrested oocytes after Prkar2b RNAi microinjection. In the MI stage for 16h to 36h, the spindle was formed and the chromosomes were aligned to split, whereas in the Prkar2b suppressed oocyte, there was no spindle formation and the chromosomes were aggregated (Fig. 5A ). In the MII stage, the polar body was clearly formed in the control group, while normal division by forming polar body did not occur in Prkar2b-deficient oocytes (Fig.  5B) . These results suggest that Prkar2b is essential for spindle formation during oocyte maturation.
Effects of Prkar2b knockdown on the expression of cAMP-dependent protein kinase related genes and oocyte metabolism related genes.
To examine the effect of Prkar2b in the expression of PKA subfamilies, RT-PCR and qRT-PCR were performed. Prkar1b and Prkar2a were showed no significant changes between control and Prkar2b RNAi treated oocytes. While Prkacb and Prkar1a were decreased, Prkaca expression was significantly increased in Prkar2b-deficient oocytes (Fig. 6A-C) . Because pentose phosphate pathway (PPP) was known to control maturation and development [30] , expression level of PPP-related factors, such as Gpi1, G6pd2, Rpe, Rpia, Tkt, Taldo1, Rbks, and Prps1. The expression levels of the majority of PPP-related genes were reduced in Prkar2b-deficient oocytes, especially in Rpe and Tkt cases (Fig. 6A, 6D-E) . These results indicated that Prkar2b regulate oocyte maturation through controlling PPP. 
Discussion
Oocyte development depends on a variety of signal pathways, such as the dynamic cellular process of asymmetric meiosis. Although there are several studies regarding this signaling pathway mechanism, the oocyte maturation process has not been thoroughly described. The role of PRKAR2B (RIIβ), a regulatory isoform of PKA, in oocyte maturation, has not been studied, even though PKA signaling is known to play an important role in oocyte maturation [31] [32] [33] [34] . Here, we investigated the expression of PRKAR2B in ovarian follicles and its critical role in oocyte development.
The few studies that explore the effects of Prkar2b signaling do so using immune cells [9, 12] , nerve cells [10] , and fat cells [13] . As our microarray analysis indicated that expression of Prkar2b was dramatically increased during dormant follicle maturation (data not shown), we hypothesized that PRKAR2B, a novel isoform of PKA, would be a critical regulator of follicle maturation and oocyte dormancy. As expected, we found that Prkar2b was more strongly expressed in large follicles, such as antral and pre-ovulatory follicles, than in small, growing follicles, such as primary and primordial follicles, and is also highly expressed in follicle GCs (Fig. 1C) . These results suggest that PRKAR2B may be essential to follicle maturation, as well as play a role in hormonal regulation of GCs. However, further studies are needed to confirm the involvement of PRKAR2B in hormonal regulation of the reproductive system through activating ovarian GCs.
In this study, we focused on the role of PRKAR2B in oocyte maturation, as the PKA family of proteins is known to regulate maturation of oocytes [34] . Oocyte maturation involves a variety of complex procedures that may include specific factors such as PRKAR2B signaling, as well as the immune and nervous systems. Masui cited that cytostatic factor and maturationpromoting factor, major regulators of the cell cycle in oocyte maturation, are closely related to protein kinases, and the phosphorylated proteins are critical for oocyte maturation through interaction with various factors [28, 35] . The novel protein kinase, PRKAR2B, is a possible candidate for a major regulator of the cell cycle of oocyte meiosis.
Newborn female ovaries contain their total number of oocytes, which are arrested at the diplotene stage of meiosis I until puberty, when luteinizing hormone surges induce the continuation of meiosis. In meiosis I, a diploid cell divides into two haploid cells; one becomes the secondary oocyte and the other forms the first polar body. These processes are MI to MII. We found that PRKAR2B expression peaked at MI stage of oocyte development, and then dropped to basal levels at MII stage (Fig. 2) . Thus, it can be inferred that PRKAR2B plays an important role in oocyte division. These results are consistent with previous reports that various factors, including PKA family proteins, play an important role in cell division of the oocyte meiosis stage [36, 37] . We also confirmed that PRKAR2B deficiency [38] results in division failure of the oocyte, as determined using time lapse video recording for 36 h (Fig. 4) . Furthermore, Prkar2b RNAi-injected oocytes could not form the polar body through abnormal division, thus we focused on spindle formation to determine the mechanism by which this phenomenon was triggered. Immunofluorescence staining of PRKAR2B-deficient oocytes showed that the α-tubulin assembly involved in formation of the spindle did not proceed in the MI stage. In addition, PRKAR2B deficiency also triggered abnormal formation of the secondary polar body (Fig. 5) . These results indicate that one of the roles of Prkar2b is to regulate spindle formation in oocyte meiosis.
In most organisms, the PPP is essential for the synthesis of nicotinamide adenine dinucleotide phosphate (NADPH), as well as five-carbon sugars [39] , nucleotides, fatty acids, and neurotransmitters [30] . Recently, several studies reported that the PPP is involved in the metabolic pathways of various cells, including cancer cells and oocytes [30, 40] . TKT, an enzyme in the PPP, plays a critical role in energy production and nucleic acid synthesis during embryonic development [41] . TKT is involved in several diseases, including Alzheimer's disease, diabetes, eye transparency, and cancer [42] [43] [44] . We found that Prkar2b deficiency results in down-regulation of Tkt mRNA expression in the MI stage of oocytes, suggesting that PRKAR2B is involved in the PPP. Furthermore, the PPP-related genes, such as Gpi1, Rpe, Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry
